Long-term follow-up of intestinal metaplasia of the gastric cardia

OBJECTIVE:Recent studies have found a relatively high prevalence of gastric cardia intestinal metaplasia in individuals presenting for elective upper endoscopy. It has been hypothesized that this lesion may be a precursor of gastric cardia cancer. Our objective was to identify the incidence of dysplasia in patients with gastric cardia intestinal metaplasia.METHODS:Twenty-eight patients who had previously been identified with cardia intestinal metaplasia had follow-up examinations performed. None of the patients had dysplasia at the time of diagnosis. All had an examination at 1 yr, and 20 patients had an examination at 3 yr after diagnosis. During follow-up examinations all patients underwent vital staining with methylene blue to help identify areas of intestinal metaplasia in the cardia. Two to four biopsies were taken from blue-stained mucosa. Histological specimens were stained using a combination of hematoxylin and eosin with Alcian blue at pH 2.5.RESULTS:There were 27 men and one woman with a mean age of 69.8 yr (range, 48–83 yr). The mean length of follow-up was 2.5 yr (range, 12–46 months). Only one patient was diagnosed with dysplasia (low-grade) during the study, for an incidence of 1.4% per yr.CONCLUSIONS:The prevalence (0%) and incidence (1.4%/yr) of dysplasia in cardia intestinal metaplasia are low. Although further studies are needed, screening and surveillance for gastric cardia intestinal metaplasia is unlikely to be clinically useful for the prevention of gastric cardia cancer.

[1]  J. Mecklin,et al.  Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease , 1999, American Journal of Gastroenterology.

[2]  L. Hansson,et al.  Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. , 1999, Journal of the National Cancer Institute.

[3]  R. Sampliner,et al.  Barrett's esophagus: update on screening, surveillance, and treatment. , 1999, Archives of internal medicine.

[4]  A. Sonnenberg,et al.  Characteristics of intestinal metaplasia in the gastric cardia , 1999, American Journal of Gastroenterology.

[5]  A. Bhattacharyya,et al.  Methylene blue staining for intestinal metaplasia of the gastric cardia with follow-up for dysplasia. , 1998, Gastrointestinal endoscopy.

[6]  J. Goldblum,et al.  Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. , 1998, Gastroenterology.

[7]  P. Malfertheiner,et al.  Prevalence and pattern of Helicobacter pylori gastritis in the gastric cardia. , 1997, The American journal of gastroenterology.

[8]  A. Bhattacharyya,et al.  Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. , 1997, The American journal of gastroenterology.

[9]  A. Bhattacharyya,et al.  Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia? , 1997, The American journal of gastroenterology.

[10]  A. Bhattacharyya,et al.  Intestinal metaplasia of the gastric cardia. , 1997, The American journal of gastroenterology.

[11]  R. Cherian,et al.  Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. , 1997, The American journal of gastroenterology.

[12]  A. Ippoliti,et al.  The diagnosis of Barrett's esophagus: goblets, goblets, goblets. , 1996, Gastrointestinal endoscopy.

[13]  L. Melton,et al.  Changes in the site- and histology-specific incidence of gastric cancer during a 50-year period. , 1995, Gastroenterology.

[14]  A. Cameron,et al.  Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. , 1995, Gastroenterology.

[15]  R. Haggitt,et al.  Barrett's esophagus, dysplasia, and adenocarcinoma. , 1994, Human pathology.

[16]  J. Peters,et al.  Is Barrett's metaplasia the source of adenocarcinomas of the cardia? , 1994, Archives of surgery.

[17]  A R Zinsmeister,et al.  Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. , 1993, Gastroenterology.

[18]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[19]  P. Correa,et al.  A human model of gastric carcinogenesis. , 1988, Cancer research.

[20]  W. Macdonald,et al.  Adenocarcinoma of the Esophagus and/or Gastric Cardia , 1987, Cancer.

[21]  W S Payne,et al.  The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. , 1985, The New England journal of medicine.

[22]  M. Orringer,et al.  Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia. , 1984, Gastroenterology.

[23]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[24]  D. Antonioli,et al.  Changes in the location and type of gastric adenocarcinoma , 1982, Cancer.

[25]  B. Morson Carcinoma Arising from Areas of Intestinal Metaplasia in the Gastric Mucosa , 1955, British Journal of Cancer.